Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

BACKGROUND: The modified Glasgow Prognostic Score (mGPS) is a composite biomarker that uses albumin and C reactive protein (CRP). There are multiple immune checkpoint inhibitor (ICI)-based combinations approved for metastatic renal cell carcinoma (mRCC). We investigated the ability of mGPS to predic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Immunother Cancer
Päätekijät: Brown, Jacqueline T, Liu, Yuan, Shabto, Julie M, Martini, Dylan, Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren, Joshi, Shreyas Subhash, Kissick, Haydn, Ogan, Kenneth, Nazha, Bassel, Carthon, Bradley C, Kucuk, Omer, Harris, Wayne B, Master, Viraj A, Bilen, Mehmet Asim
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2021
Aiheet:
Immunotherapy Biomarkers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323383/
https://ncbi.nlm.nih.gov/pubmed/34326170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002851
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia